Tue 21 Aug 2018 09:29:31 PM CDT: This site is about to be upgraded to a new software release. If you are in the process of entering information, please complete it in the next few minutes and then log off, to ensure that you are not interrupted. If you were about to start entering details, please wait until this message is removed. You may continue to browse content on the site during the upgrade if you wish. We apologize for any inconvenience this may cause.
Donald Calne Lecture
Presenter: Dr. Robert L. Nussbaum
Dr. Robert Nussbaum will speak about genetics and Parkinson’s disease.
Dr. Nussbaum directed the original research that led to the discovery of mutations in alpha-synuclein in hereditary Parkinson disease in the mid-1990s and has been studying its role in Parkinson’s disease ever since.
Dr. Nussbaum received his training in medicine in the Harvard-MIT Joint Program in Health Technology, his internal medicine training at Barnes Hospital/Washington University, and his genetics training at Baylor College of Medicine. He is board certified in internal medicine, clinical genetics and clinical molecular genetics. Dr. Nussbaum is currently the Chief Medical Officer for Invitae, a genetic testing and information company, based in San Francisco, U.S.A.
Advance registration and onsite check-in are required as seating is limited.
About the Donald Calne Lecture
Finding better ways detect, diagnose, treat and ultimately, cure Parkinson’s requires cooperation from a global scientific community. The Donald Calne Lectureship, established in Canada in 2002, honours research that makes an impact on the world stage. Each year, the award celebrates a distinguished neuroscientist whose research is helping us learn more about how to prevent, diagnose, and treat Parkinson’s. The recipient gives a speech, on the state of Parkinson’s research, to Canadian scientists, medical professionals, people with Parkinson’s and their families. Visit www.parkinson.ca for more information on this and previous Donald Calne Lectures.